United States: Pfizer Requests Full Approval Of Its COVID-19 Vaccine - Ballard Spahr LLP

On Friday, May 7, Pfizer and its partner BioNTech filed an application seeking full approval from the United States Food and Drug Administration (FDA) for its COVID-19 vaccine for patients age...